General Principles of Pharmacology and Toxicology

Size: px
Start display at page:

Download "General Principles of Pharmacology and Toxicology"

Transcription

1 General Principles of Pharmacology and Toxicology Parisa Gazerani, Pharm D, PhD Assistant Professor Center for Sensory-Motor Interaction (SMI) Department of Health Science and Technology Aalborg University

2 Pharmacokinetics II 2

3 3 Pharmacokinetics made easy! In pharmacokinetics the body is represented as a single or multiple compartments in to which the drug is distributed. Volume of Distribution = Dose/Plasma Concentration Clearance = Elimination Rate Constant x Volume of Distribution (CL = kv) Loading dose = Cp(Target) x VD Maintenance Dose = CL x CpSSav (target average steady state drug concentration)

4 4 Question 1 What Is the is the loading dose required for drug A if: Target concentration is 10 mg/l VD is 0.75 L/kg Patients weight is 75 kg Answer is on the next slide

5 5 Answer Loading Dose of Drug A VD = 0.75 L/kg x 75 kg = L Target Conc. = 10 mg/l Loading Dose = Target Concentration x VD Loading Dose = 10 mg/l x L = 565 mg This would probably be rounded to 560 or even 500 mg.

6 6 Question 2 What maintenance dose is required for drug B if: Target average SS concentration is 10 mg/l CL of drug A is L/kg/hr Patient weighs 75 kg Answer is on the next slide

7 7 Answer Maintenance Dose of Drug B Maintenance Dose = CL x CpSS av CL = L/hr/kg x 75kg = L/hr Dose = L/hr x 10 mg/l = mg/hr So will need x 24 mg per day = 270 mg

8 8 Half-life is the time taken for the drug concentration to fall to half its original value The elimination rate constant (k) is the fraction of drug in the body which is removed per unit time. Drug Concentration C 1 C 2 Time

9 9 C 0 t1/2 = 0.693/k Log Concn. C 0 /2 t 1/2 t 1/2 t 1/2 Time Time to eliminate ~ 4 t 1/2

10 10 Steady-state (SS) Steady-state occurs after a drug has been given for approximately five elimination half-lives. At steady-state the rate of drug administration equals the rate of elimination and plasma concentration - time curves found after each dose should be approximately superimposable. Rate in = Rate Out Reached in 4 5 half-lives (linear kinetics) Important when interpreting drug concentrations in TDM or assessing clinical response

11 11 Accumulation to Steady State 100 mg given every half-life

12 12 C Cp av t Four half lives to reach steady state

13 13 Elimination of a drug refers to: a) Excretion of its breakdown products in the urine b) Renal excretion of the unchanged drug c) Uptake of drug from the blood into the liver d) Metabolism of the drug in the liver e) Distribution of the drug into fat Correct answers: b, d

14 14 The elimination rate of a drug is: a) A constant for a particular drug and patient b) The extent to which it is excreted in urine c) Directly proportional to the plasma drug concentration d) Directly proportional to the clearance e) The extent to which the drug is excreted in the faeces Correct answers: c, d

15 15 Clearance: a) Depends on the elimination rate b) Refers to the efficiency of elimination of drug by an organ or the whole body c) Cannot be greater than blood flow to an organ d) Determines the steay state drug concentration during constant dosing e) Is determined by the half-life Correct answers: b, c, d

16 16 Two definition of clearance are: a) The volume of blood or plasma irreversibly cleared of drug per unit time b) The time taken to reduce the plasma concentration by half c) The constant relating the rate of elimination of a drug to the plasma drug concentration d) The amount of drug metabolized per unit time e) The amount of drug excreted in urine per unit time Correct answers: a, c

17 17 Volume of distribution is: a) The total volume of the body b) The volume of the extracellular fluid c) Equal to the volume of total body water d) The constant relating amount of drug in the body to the plasma drug concentration e) The volume of the body minus the blood volume Correct answer: d

18 18 The loading dose of a drug is determined by: a) The clearance b) The elimination rate c) The target plasma drug concentration d) The volume of distribution e) The molecular weight of drug Correct answers: c, d

19 19 The rate of distribution of a drug can determine: a) The volume of distribution b) The onset of drug effect c) The rate of drug elimination d) The duration of drug effect e) The clearance Correct answers: b, d

20 20 Volume of distribution can be measured using: a) The plasma drug concentration extrapolated back to zero time after administration b) The rate of elimination at a particulatr time after the dose c) The clearance d) The rate of onset of drug effect e) The duration of drug effect Correct answer: a

21 21 Half-life: a) Is the time taken for the plasma concentration to fall by half b) Has units of per hour c) Is the time taken for the amount of drug in the body to fall by half d) Decreases as elimination constant increases e) Increases as the elimination constant increases Correct answers: a, c, d

22 22 After a single dose of a drug which has a half life of 12 hours, what percentage of the dose is still in the body after 1 day? a) 87.5% b) 75% c) 50% d) 25% e) 12.5% Correct answer: d

23 23 During a constant rate intravenous infusion of a drug with an elimination rate constant of per hour, the plasma drug concentration will be what percentage of steady state after 16 hours? a) 25% b) 50% c) 75% d) 87.5% e) 93.75% Correct answer: e

24 24 Half-life determines: a) The loading dose b) The time to reach steady state c) The drug concentration at steady state during constant dosing d) The duration of action after a single dose e) The flactuation in plasma drug concentration during a dosing interval Correct answers: b, d, e

25 25 Bioavailability: a) Is the extent to which a drug is absorbed from the gut b) Is the fraction of the drug metabolized first pass by liver c) Is the fraction of the dose reaching the systemic circulation intact d) Is a measure of both first-pass metabolism and absorption from the gut e) Only refers to intravenous drug administration Correct answers: c, d

26 26 A new generic drug is tested in a bioavailability study against the innovator brand. The AUC oral for the generic is 1200 mg*hour/l and that for the innovator brand is 1000 mg*hour/l a) The relative bioavailability of the generic formulation compared to the innovator brand is 1.2 b) The absolute bioavailability of the innovator brand is 1.0 c) The generic formulation would usually be regarded as bioequivalent to the innovator brand d) The absolue bioavailability of the innovator brand is 0.83 e) The generic brand is better than the innovator brand Correct answers: a, c

27 27 Which of the following routs of administration completely avoid first-pass clearance? a) Buccal b) Sublingual c) Rectal d) Oral e) Transdermal Correct answers: a, b, e

28 28 With respect to the renal clearance of drugs by glomerular filtration: a) Glumerular filtration rate is about 40% of renal blood flow b) Only unbound drug is filtered c) Drug clearance by glumerular filtration is equal to glomerular filtration rate d) Both bound and unbound drug can be filtered Correct answer: b

29 29 The proportion of drug re-absorbed from the renal tubule depends on: a) The glomerular filtration rate b) The urine flow rate c) The extent of drug secretion into the renal tubule d) The liphophilicity of the non-ionized drug e) The urine ph Correct answers: b, d, e

30 30 The renal clearance of a lipophilic drug which is a weak acid with a pka of 5.0 is likely to be: a) Reduced by cimetidine b) Reduced by probenecid c) Increased by acidifying the urine d) Increase by alkalinizing the urine e) Increased by an increase in urine flow rate Correct answers: b, d, e

31 31 The fraction of a drug unbound in plasma is: a) Usually not affected by the drug concentration b) Independent of the concentration of binding protein c) Dependent on the affinity of drug for the binding protein d) Usually increased as drug concentration increases e) Usually decreases as drug concentration increases Correct answers: a, c

32 32 The AUC for the plasma concentration versus time curve of a drug after a single intravenous dose is determined by: a) Volume of distribution b) Dose c) Half-life d) Clearance e) bioavailability Correct answers: b, d

33 33 Calculation of the volume of distribution of a drug after a single oral dose requires which of the following parameters? a) The time of max plasma concentration b) The clearance c) The elimination rate constant or half-life d) The bioavailability e) The absorption rate constant Correct answers: b, c, d

34 34 Explore it! Table gives plasma drug concentrations (Cp) obtained following an intravenous bolus administration of a 250 mg dose of a drug that exhibited the characteristics of a onecompartment model and was eliminated exclusively by urinary excretion. Time (h) Plasma Con. (ug/ml)

35 35 Plotting the data revealed the following: a) The elimination half life (t 1/2 ) =1.275 h b) The overal elimination rate constant (K) = 0.543/h c) The intial plasma concentration (Cp) 0 = 90 ug/ml 100 Intercept = initial plasma conc. Drug conc 10 5 Slope= -K/2.303 t1/2 1 Time (h)

36 36 Questions a) The apparent volume of distribution (Vd)? V = Dose/(Cp) 0 b) The drug plasma concentration at 75 min following the administration of a 2.5 mg/kg dose to a subject weighting 70 kg? c) The time at which the plasma concentration of the drug will fall below 20 ug/ml, following the administration of a 275 mg dose? Cp = (Cp) 0 e Kt or Cp/(Cp) 0 = e Kt or Ln (Cp/(Cp) 0 )/-K = t

37 37 Answer V = Dose/(Cp) 0 V= 250/90= 2.77 L (Cp) 0 = Dose/V (Cp) 0 = 175/2.77 = Cp = (Cp) 0 e Kt Cp = e x 75min or 1.25 h = (Cp) 0 = Dose/V (Cp) 0 = ug/2770 ml = ug/ml t = Ln (Cp/(Cp) 0 )/-K t = Ln (20/99.277) = 2.94 h

38 38 Take a closer look! Find more problem sets with answers in this book.

39 39 Take a closer look! Find more self-test questions with answers in this book.

General Principles of Pharmacology and Toxicology

General Principles of Pharmacology and Toxicology General Principles of Pharmacology and Toxicology Parisa Gazerani, Pharm D, PhD Assistant Professor Center for Sensory-Motor Interaction (SMI) Department of Health Science and Technology Aalborg University

More information

PHA Final Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

PHA Final Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment. PHA 5127 Final Exam Fall 2012 On my honor, I have neither given nor received unauthorized aid in doing this assignment. Name Please transfer the answers onto the bubble sheet. The question number refers

More information

PHA Final Exam Fall 2006

PHA Final Exam Fall 2006 PHA 5127 Final Exam Fall 2006 On my honor, I have neither given nor received unauthorized aid in doing this assignment. Name Please transfer the answers onto the bubble sheet. The question number refers

More information

1. If the MTC is 100 ng/ml and the MEC is 0.12 ng/ml, which of the following dosing regimen(s) are in the therapeutic window?

1. If the MTC is 100 ng/ml and the MEC is 0.12 ng/ml, which of the following dosing regimen(s) are in the therapeutic window? Page 1 PHAR 750: Biopharmaceutics/Pharmacokinetics October 23, 2009 - Form 1 Name: Total 100 points Please choose the BEST answer of those provided. For numerical answers, choose none of the above if your

More information

BASIC PHARMACOKINETICS

BASIC PHARMACOKINETICS BASIC PHARMACOKINETICS MOHSEN A. HEDAYA CRC Press Taylor & Francis Croup Boca Raton London New York CRC Press is an imprint of the Taylor & Francis Group, an informa business Table of Contents Chapter

More information

PHA 5127 FINAL EXAM FALL On my honor, I have neither given nor received unauthorized aid in doing this assignment.

PHA 5127 FINAL EXAM FALL On my honor, I have neither given nor received unauthorized aid in doing this assignment. PHA 5127 FINAL EXAM FALL 1997 On my honor, I have neither given nor received unauthorized aid in doing this assignment. Name Question Points 1. /14 pts 2. /10 pts 3. /8 pts 4 /8 pts 5. /12 pts 6. /8 pts

More information

Renal Function. 1. Glomerular filtration 2. Active tubular secretion 3. Passive tubular reabsorption 4. Excretion

Renal Function. 1. Glomerular filtration 2. Active tubular secretion 3. Passive tubular reabsorption 4. Excretion 59-291 Section 1, Lecture 5 Drug Excretion -most drugs are excreted in urine either as unchanged or drug metabolites Renal Function 1. Glomerular filtration 2. Active tubular secretion 3. Passive tubular

More information

One-Compartment Open Model: Intravenous Bolus Administration:

One-Compartment Open Model: Intravenous Bolus Administration: One-Compartment Open Model: Intravenous Bolus Administration: Introduction The most common and most desirable route of drug administration is orally by mouth using tablets, capsules, or oral solutions.

More information

CLINICAL PHARMACOKINETICS INDEPENDENT LEARNING MODULE

CLINICAL PHARMACOKINETICS INDEPENDENT LEARNING MODULE CLINICAL PHARMACOKINETICS INDEPENDENT LEARNING MODULE Joseph K. Ritter, Ph.D. Assoc. Professor, Pharmacology and Toxicology MSB 536, 828-1022, jritter@vcu.edu This self study module will reinforce the

More information

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 3,900 116,000 120M Open access books available International authors and editors Downloads Our

More information

PHA First Exam Fall 2003

PHA First Exam Fall 2003 PHA 5127 First Exam Fall 2003 On my honor, I have neither given nor received unauthorized aid in doing this assignment. Name Question/Points 1. /14 pts 2. /6 pts 3. /15 pts 4. /12 pts 5. /20 pts 6. /10pts

More information

PHARMACOKINETICS SMALL GROUP I:

PHARMACOKINETICS SMALL GROUP I: PHARMACOKINETICS SMALL GROUP I: Question 1 Absorption of the anti-fungal agent, itraconazole, is dependent on a low gastric ph. Calculate the relative concentrations of a weak acid (with a pka of 5.4)

More information

Multiple IV Bolus Dose Administration

Multiple IV Bolus Dose Administration PHARMACOKINETICS Multiple IV Bolus Dose Administration ١ Multiple IV Bolus Dose Administration Objectives: 1) To understand drug accumulation after repeated dose administration 2) To recognize and use

More information

PHA Second Exam Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

PHA Second Exam Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment. PHA 5127 Second Exam Fall 2013 On my honor, I have neither given nor received unauthorized aid in doing this assignment. Name Question/Points Set I 20 pts Set II 20 pts Set III 20 pts Set IV 20 pts Set

More information

Basic Pharmacokinetic Principles Stephen P. Roush, Pharm.D. Clinical Coordinator, Department of Pharmacy

Basic Pharmacokinetic Principles Stephen P. Roush, Pharm.D. Clinical Coordinator, Department of Pharmacy Basic Pharmacokinetic Principles Stephen P. Roush, Pharm.D. Clinical Coordinator, Department of Pharmacy I. General principles Applied pharmacokinetics - the process of using drug concentrations, pharmaco-kinetic

More information

Determination of bioavailability

Determination of bioavailability Pharmaceutics 2 Bioavailability Bioavailability is the rate and extent to which an administered drug reaches the systemic circulation. For example, if 100 mg of a drug is administered orally and 70 mg

More information

Pharmacokinetics Overview

Pharmacokinetics Overview Pharmacokinetics Overview Disclaimer: This handout and the associated lectures are intended as a very superficial overview of pharmacokinetics. Summary of Important Terms and Concepts - Absorption, peak

More information

Basic Pharmacokinetics and Pharmacodynamics: An Integrated Textbook with Computer Simulations

Basic Pharmacokinetics and Pharmacodynamics: An Integrated Textbook with Computer Simulations Basic Pharmacokinetics and Pharmacodynamics: An Integrated Textbook with Computer Simulations Rosenbaum, Sara E. ISBN-13: 9780470569061 Table of Contents 1 Introduction to Pharmacokinetics and Pharmacodynamics.

More information

BIOPHARMACEUTICS and CLINICAL PHARMACY

BIOPHARMACEUTICS and CLINICAL PHARMACY 11 years papers covered BIOPHARMACEUTICS and CLINICAL PHARMACY IV B.Pharm II Semester, Andhra University Topics: Absorption Distribution Protein binding Metabolism Excretion Bioavailability Drug Interactions

More information

Lippincott Questions Pharmacology

Lippincott Questions Pharmacology Lippincott Questions Pharmacology Edition Two: Chapter One: 1.Which one of the following statements is CORRECT? A. Weak bases are absorbed efficiently across the epithelial cells of the stomach. B. Coadministration

More information

Basic Concepts of TDM

Basic Concepts of TDM TDM Lecture 1 5 th stage What is TDM? Basic Concepts of TDM Therapeutic drug monitoring (TDM) is a branch of clinical pharmacology that specializes in the measurement of medication concentrations in blood.

More information

ADME Review. Dr. Joe Ritter Associate Professor of Pharmacology

ADME Review. Dr. Joe Ritter Associate Professor of Pharmacology ADME Review Dr. Joe Ritter Associate Professor of Pharmacology 828-1022 jkritter@vcu.edu What percent of a weak base (pka = 7.5) and weak acid (pka = 3.5) will be respectively ionized in urine of ph 5.5?

More information

PHA Final Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

PHA Final Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment. PHA 5127 Final Exam Fall 2010 On my honor, I have neither given nor received unauthorized aid in doing this assignment. Name Please transfer the answers onto the bubble sheet. The question number refers

More information

Basic Concepts in Pharmacokinetics. Leon Aarons Manchester Pharmacy School University of Manchester

Basic Concepts in Pharmacokinetics. Leon Aarons Manchester Pharmacy School University of Manchester Basic Concepts in Pharmacokinetics Leon Aarons Manchester Pharmacy School University of Manchester Objectives 1. Define pharmacokinetics 2. Describe absorption 3. Describe distribution 4. Describe elimination

More information

Rational Dose Prediction. Pharmacology. φαρμακον. What does this mean? pharmakon. Medicine Poison Magic Spell

Rational Dose Prediction. Pharmacology. φαρμακον. What does this mean? pharmakon. Medicine Poison Magic Spell 1 Rational Dose Prediction Nick Holford Dept Pharmacology & Clinical Pharmacology University of Auckland, New Zealand 2 Pharmacology Pharmacology is derived from a Greek word (pharmakon). The Greeks used

More information

PHA Second Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

PHA Second Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment. PHA 5127 Second Exam Fall 2012 On my honor, I have neither given nor received unauthorized aid in doing this assignment. Name Put all answers on the bubble sheet TOTAL /150 pts 1 Question Set I (True or

More information

PHA First Exam. Fall 2004

PHA First Exam. Fall 2004 PHA 5127 First Exam Fall 2004 On my honor, I have neither given nor received unauthorized aid in doing this assignment. Name Put all answers on the bubble sheet. If you need to comment or question a problem

More information

PHA Second Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

PHA Second Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment. PHA 5127 Second Exam Fall 2011 On my honor, I have neither given nor received unauthorized aid in doing this assignment. Name Put all answers on the bubble sheet TOTAL /200 pts 1 Question Set I (True or

More information

PHA5128 Dose Optimization II Case Study I Spring 2013

PHA5128 Dose Optimization II Case Study I Spring 2013 Silsamicin is an investigational compound being evaluated for its antimicrobial effect. The route of administration for this drug is via intravenous bolus. Approximately 99.9% of this drug is eliminated

More information

PHA 4120 Second Exam Key Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

PHA 4120 Second Exam Key Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment. PHA 4120 Second Exam Key Fall 1997 On my honor, I have neither given nor received unauthorized aid in doing this assignment. Name Question Points 1. /10 ponts 2. /20 points 3. /10 points 4. /10 points

More information

Name: UFID: PHA Exam 2. Spring 2013

Name: UFID: PHA Exam 2. Spring 2013 PHA 5128 Exam 2 Spring 2013 1 Carbamazepine (5 points) 2 Theophylline (10 points) 3 Gentamicin (10 points) 4 Drug-drug interaction (5 points) 5 Lidocaine (5 points) 6 Cyclosporine (5 points) 7 Phenobarbital

More information

Pharmacokinetics in Drug Development. Edward P. Acosta, PharmD Professor & Director Division of Clinical Pharmacology Director, CCC PK/PD Core

Pharmacokinetics in Drug Development. Edward P. Acosta, PharmD Professor & Director Division of Clinical Pharmacology Director, CCC PK/PD Core Pharmacokinetics in Drug Development Edward P. Acosta, PharmD Professor & Director Division of Clinical Pharmacology Director, CCC PK/PD Core Finding new drugs: A crap shoot Clinical Development Phase

More information

Nonlinear Pharmacokinetics

Nonlinear Pharmacokinetics Nonlinear Pharmacokinetics Non linear pharmacokinetics: In some cases, the kinetics of a pharmacokinetic process change from predominantly first order to predominantly zero order with increasing dose or

More information

PHA Spring First Exam. 8 Aminoglycosides (5 points)

PHA Spring First Exam. 8 Aminoglycosides (5 points) PHA 5128 Spring 2012 First Exam 1 Aminoglycosides (5 points) 2 Aminoglycosides (10 points) 3 Basic Principles (5 points) 4 Basic Principles (5 points) 5 Bioavailability (5 points) 6 Vancomycin (5 points)

More information

Pharmacokinetics One- compartment Open Model Lec:2

Pharmacokinetics One- compartment Open Model Lec:2 22 Pharmacokinetics One- compartment Open Model Lec:2 Ali Y Ali BSc Pharmacy MSc Industrial Pharmaceutical Sciences Dept. of Pharmaceutics School of Pharmacy University of Sulaimani 1 Outline Introduction

More information

Excretion of Drugs. Prof. Hanan Hagar Pharmacology Unit Medical College

Excretion of Drugs. Prof. Hanan Hagar Pharmacology Unit Medical College Excretion of Drugs Prof. Hanan Hagar Pharmacology Unit Medical College Excretion of Drugs By the end of this lecture, students should be able to! Identify main and minor routes of excretion including renal

More information

PHAR 7633 Chapter 20 Non Compartmental Analysis

PHAR 7633 Chapter 20 Non Compartmental Analysis Student Objectives for this Chapter PHAR 7633 Chapter 20 Non Compartmental Analysis To understand and use the non compartmental approach to parameter estimation be able to define, use, and calculate the

More information

Dr. M.Mothilal Assistant professor

Dr. M.Mothilal Assistant professor Dr. M.Mothilal Assistant professor Bioavailability is a measurement of the rate and extent of drug that reaches the systemic circulation from a drug product or a dosage form. There are two different types

More information

Introduction to. Pharmacokinetics. University of Hawai i Hilo Pre-Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D

Introduction to. Pharmacokinetics. University of Hawai i Hilo Pre-Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D Introduction to 1 Pharmacokinetics University of Hawai i Hilo Pre-Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D 2 Learning objectives Understand compartment models and how they effects

More information

Pharmacokinetics of Drugs. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia

Pharmacokinetics of Drugs. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia Pharmacokinetics of Drugs Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia Absorption Is the transfer of a drug from its site of administration to the bloodstream.

More information

. Although there is a little

. Although there is a little PHA 58 Spring 007 Case study 4. Baby girl A, 3kg, 5 days, is receiving phenobarbital because of neonatal seizures. An IV loading dose of phenobarbital sodium of 0mg/kg was given followed by maintenance

More information

What is pharmacokinetics?

What is pharmacokinetics? Pharmacokinetics What is pharmacokinetics? Study of the time course of a drug s movement through the body. Understanding of what the body does to (or with) the drug. Application of Therapeutic Drug Monitoring

More information

WHY... 8/21/2013 LEARNING OUTCOMES PHARMACOKINETICS I. A Absorption. D Distribution DEFINITION ADME AND THERAPEUIC ACTION

WHY... 8/21/2013 LEARNING OUTCOMES PHARMACOKINETICS I. A Absorption. D Distribution DEFINITION ADME AND THERAPEUIC ACTION PHARMACOKINETICS I Absorption & Distribution LEARNING OUTCOMES By the end of the lecture students will be able to.. Dr Ruwan Parakramawansha MBBS, MD, MRCP(UK),MRCPE, DMT(UK) (2013/08/21) Define pharmacokinetics,

More information

Introduction to. Pharmacokinetics. University of Hawai i Hilo Pre-Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D

Introduction to. Pharmacokinetics. University of Hawai i Hilo Pre-Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D Introduction to 1 Pharmacokinetics University of Hawai i Hilo Pre-Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D 2 Learning objectives Understand compartment models and how they effects

More information

LD = (Vd x Cp)/F (Vd x Cp)/F MD = (Css x CL x T)/F DR = (Css x (Vm-DR))/Km Css = (F x D)/(CL x T) (Km x DR)/(Vm DR)

LD = (Vd x Cp)/F (Vd x Cp)/F MD = (Css x CL x T)/F DR = (Css x (Vm-DR))/Km Css = (F x D)/(CL x T) (Km x DR)/(Vm DR) PHARMKIN WORKSHOP A PHARMACOKINETICS TEACHING SIMULATION Joseph K. Ritter, Ph.D. Associate Professor, Pharmacology and Toxicology MSB 536, 828-1022, jritter@mail2.vcu.edu Tompkins-McCaw Libray Room 2-006

More information

The general Concepts of Pharmacokinetics

The general Concepts of Pharmacokinetics The general Concepts of Pharmacokinetics What is this jargon? Is it useful? C max, clearance, Vd, half-life, AUC, bioavailability, protein binding F. Van Bambeke, E. Ampe, P.M. Tulkens (Université catholique

More information

PHAR 7632 Chapter 16

PHAR 7632 Chapter 16 PHAR 7632 Chapter 16 Routes of Excretion Routes of Excretion Student Objectives for this Chapter After completing the material in this chapter each student should:- be able to describe the various routes

More information

Nontraditional PharmD Program PRDO 7700 Pharmacokinetics Review Self-Assessment

Nontraditional PharmD Program PRDO 7700 Pharmacokinetics Review Self-Assessment Nontraditional PharmD Program PRDO 7700 Pharmacokinetics Review Self-Assessment Please consider the following questions. If you do not feel confident about the material being covered, then it is recommended

More information

INTRODUCTION TO PHARMACOKINETICS

INTRODUCTION TO PHARMACOKINETICS INTRODUCTION TO PHARMACOKINETICS 1 http://www.biology.iupui.edu/biocourses/biol540/4pipeline2css.html 2 PHARMACOKINETICS 1. ABSORPTION 2. DISTRIBUTION 3. METABOLISM 4. EXCRETION ALL THESE PROCESSES ARE

More information

Winston Spencer Liauw Cancer Care Centre, St George Hospital, Gray Street, Kogarah NSW 2217, Australia

Winston Spencer Liauw Cancer Care Centre, St George Hospital, Gray Street, Kogarah NSW 2217, Australia LINIAL PARMAOLOGY Winston Spencer Liauw ancer are entre, St George ospital, Gray Street, Kogarah NSW 2217, Australia Keywords: linical pharmacology, pharmacology, pharmacokinetics, pharmacodynamics, therapeutics,

More information

C OBJECTIVES. Basic Pharmacokinetics LESSON. After completing Lesson 2, you should be able to:

C OBJECTIVES. Basic Pharmacokinetics LESSON. After completing Lesson 2, you should be able to: LESSON 2 Basic Pharmacokinetics C OBJECTIVES After completing Lesson 2, you should be able to: 1. Define the concept of apparent volume of distribution and use an appropriate mathematical equation to calculate

More information

PHA Final Exam Fall 2001

PHA Final Exam Fall 2001 PHA 5127 Final Exam Fall 2001 On my honor, I have neither given nor received unauthorized aid in doing this assignment. Name Question/Points 1. /12 pts 2. /8 pts 3. /12 pts 4. /20 pts 5. /27 pts 6. /15

More information

Pharmacokinetic parameters: Halflife

Pharmacokinetic parameters: Halflife Pharmacokinetic parameters: Halflife (t 1/2 ) 1. By definition t 1/2 is the time required for the concentration to fall by one half. For drugs with first order kinetics this is a constant. 2. Half-life

More information

Adjusting phenytoin dosage in complex patients: how to win friends and influence patient outcomes

Adjusting phenytoin dosage in complex patients: how to win friends and influence patient outcomes Adjusting phenytoin dosage in complex patients: how to win friends and influence patient outcomes Brian Hardy, PharmD, FCSHP, FCCP Coordinator Education and Clinical Programs Department of Pharmacy Sunnybrook

More information

The importance of clearance

The importance of clearance The importance of clearance The calculation of clearance can be especially useful in optimizing dosing of patients The clearance includes both the volume of distribution and the elimination rate The clearance

More information

Pharmacokinetics Applied to the Treatment of Asthma

Pharmacokinetics Applied to the Treatment of Asthma Pharmacokinetics Applied to the Treatment of Asthma 2016 edition by David C. McMillan, PhD Department of Pharmacology and Experimental Neuroscience College of Medicine University of Nebraska Medical Center

More information

PHA Second Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

PHA Second Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment. PHA 5127 Second Exam Fall 2010 On my honor, I have neither given nor received unauthorized aid in doing this assignment. Name Put all answers on the bubble sheet TOTAL /200 pts 1 Question Set I (True or

More information

Introduction to Pharmacokinetics (PK) Anson K. Abraham, Ph.D. Associate Principal Scientist, PPDM- QP2 Merck & Co. Inc., West Point, PA 5- June- 2017

Introduction to Pharmacokinetics (PK) Anson K. Abraham, Ph.D. Associate Principal Scientist, PPDM- QP2 Merck & Co. Inc., West Point, PA 5- June- 2017 Introduction to Pharmacokinetics (PK) Anson K. Abraham, Ph.D. Associate Principal Scientist, PPDM- QP2 Merck & Co. Inc., West Point, PA 5- June- 2017 1 Outline Definition & Relevance of Pharmacokinetics

More information

Principles of Toxicokinetics/Toxicodynanics

Principles of Toxicokinetics/Toxicodynanics Biochemical and Molecular Toxicology ENVR 442; TOXC 442; BIOC 442 Principles of Toxicokinetics/Toxicodynanics Kim L.R. Brouwer, PharmD, PhD kbrouwer@unc.edu; 919-962-7030 Pharmacokinetics/ Toxicokinetics:

More information

Pharmacokinetics I. Dr. M.Mothilal Assistant professor

Pharmacokinetics I. Dr. M.Mothilal Assistant professor Pharmacokinetics I Dr. M.Mothilal Assistant professor DRUG TRANSPORT For a drug to produce a therapeutic effect, it must reach to its target and it must accumulate at that site to reach to the minimum

More information

Section 5.2: Pharmacokinetic properties

Section 5.2: Pharmacokinetic properties Section 5.2: Pharmacokinetic properties SmPC training presentation Note: for full information refer to the European Commission s Guideline on summary of product characteristics (SmPC) SmPC Advisory Group

More information

TDM. Measurement techniques used to determine cyclosporine level include:

TDM. Measurement techniques used to determine cyclosporine level include: TDM Lecture 15: Cyclosporine. Cyclosporine is a cyclic polypeptide medication with immunosuppressant effect. It has the ability to block the production of interleukin-2 and other cytokines by T-lymphocytes.

More information

PHARMACOKINETICS SMALL GROUP II:

PHARMACOKINETICS SMALL GROUP II: PHARMACOKINETICS SMALL GROUP II: Question 1 Why are some drug therapies initiated with a loading dose? Emphasize that LD establishes initial therapeutic level quickly. The time to reach the steady-state

More information

Slide 1. Slide 2. Slide 3. Drug Action and Handling. Lesson 2.1. Lesson 2.1. Drug Action and Handling. Drug Action and Handling.

Slide 1. Slide 2. Slide 3. Drug Action and Handling. Lesson 2.1. Lesson 2.1. Drug Action and Handling. Drug Action and Handling. Slide 1 Drug Action and Handling Chapter 2 1 Slide 2 Lesson 2.1 Drug Action and Handling 1. Differentiate dose, potency, and efficacy in the context of the actions of drugs. 2. Explain the pharmacologic

More information

PHARMACOKINETICS OF DRUG ABSORPTION

PHARMACOKINETICS OF DRUG ABSORPTION Print Close Window Note: Large images and tables on this page may necessitate printing in landscape mode. Applied Biopharmaceutics & Pharmacokinetics > Chapter 7. Pharmacokinetics of Oral Absorption >

More information

PHA 5128 Final Exam Spring 2004 Version A. On my honor, I have neither given nor received unauthorized aid in doing this assignment.

PHA 5128 Final Exam Spring 2004 Version A. On my honor, I have neither given nor received unauthorized aid in doing this assignment. PHA 5128 Final Exam Spring 2004 Version A On my honor, I have neither given nor received unauthorized aid in doing this assignment. Name There are 18 questions. Total /120 pts Final 2004 1 1. T.P., a 66-year-old,

More information

Click to edit Master title style

Click to edit Master title style A Short Course in Pharmacokinetics Chris Town Research Pharmacokinetics Outline Pharmacokinetics - Definition Ideal Pharmacokinetic Parameters of a New Drug How do we optimize PK for new compounds Why

More information

AMINOGLYCOSIDES TDM D O N E B Y

AMINOGLYCOSIDES TDM D O N E B Y AMINOGLYCOSIDES TDM DONE BY: SARA ALARFAJ 2014 OUTLINE Introduction about Aminoglycosides. Spectrum/uses. TDM Aminoglycosides TDM Pharmacodynamics Pharmacokinetics. Dosing in AG. Sampeling time and Monitoring.

More information

Drug Dosing in Renal Insufficiency. Coralie Therese D. Dimacali, MD College of Medicine University of the Philippines Manila

Drug Dosing in Renal Insufficiency. Coralie Therese D. Dimacali, MD College of Medicine University of the Philippines Manila Drug Dosing in Renal Insufficiency Coralie Therese D. Dimacali, MD College of Medicine University of the Philippines Manila Declaration of Conflict of Interest For today s lecture on Drug Dosing in Renal

More information

Pharmacokinetics PCTH 325. Dr. Shabbits September 12, C t = C 0 e -kt. Learning Objectives

Pharmacokinetics PCTH 325. Dr. Shabbits September 12, C t = C 0 e -kt. Learning Objectives PCTH 325 Pharmacokinetics Dr. Shabbits jennifer.shabbits@ubc.ca September 12, 2013 Learning Objectives 1. Interpret Concentration vs graphs and use them to calculate half life and predict drug concentration

More information

PHA 5128 CASE STUDY 5 (Digoxin, Cyclosporine, and Methotrexate) Spring 2007

PHA 5128 CASE STUDY 5 (Digoxin, Cyclosporine, and Methotrexate) Spring 2007 PHA 5128 CASE STUDY 5 (Digoxin, Cyclosporine, and Methotrexate) Spring 2007 1. L.J., a 30 year old male, was diagnosed congestive heart failure (CHF). He is 5'9" tall and weights 80 kg. He was given Furosemide

More information

UNIVERSITY OF THE WEST INDIES, ST AUGUSTINE

UNIVERSITY OF THE WEST INDIES, ST AUGUSTINE UNIVERSITY OF THE WEST INDIES, ST AUGUSTINE FACULTY OF MEDICAL SCIENCES SCHOOL OF PHARMACY BACHELOR OF SCIENCE IN PHARMACY DEGREE COURSE SYLLABUS COURSE TITLE: COURSE CODE: BIOPHARMACEUTICS, NEW DRUG DELIVERY

More information

Understand the physiological determinants of extent and rate of absorption

Understand the physiological determinants of extent and rate of absorption Absorption and Half-Life Nick Holford Dept Pharmacology & Clinical Pharmacology University of Auckland, New Zealand Objectives Understand the physiological determinants of extent and rate of absorption

More information

Case Study 2 Answers Spring 2006

Case Study 2 Answers Spring 2006 Case Study 2 Answers Spring 2006 1. The volume of distribution of diazepam in a group of normal subjects (60 kg, ideal body weight) was found to be 105 L. In another group of patients (110 kg), the volume

More information

Pharmacodynamics & Pharmacokinetics 1

Pharmacodynamics & Pharmacokinetics 1 PCTH 325 Pharmacodynamics & Pharmacokinetics 1 Dr. Shabbits jennifer.shabbits@ubc.ca September 9, 2014 Learning objectives 1. Describe the categories of intended drug action 2. Compare and contrast agonists

More information

Drug Distribution. Joseph K. Ritter, Ph.D., Assoc. Prof. Medical Sciences Building, Room

Drug Distribution. Joseph K. Ritter, Ph.D., Assoc. Prof. Medical Sciences Building, Room Drug Distribution Joseph K. Ritter, Ph.D., Assoc. Prof. Medical Sciences Building, Room 531 jkritter@vcu.edu 828-1022 Department of Pharmacology and Toxicology Medical College of Virginia Campus Virginia

More information

Basic Biopharmaceutics, Pharmacokinetics, and Pharmacodynamics

Basic Biopharmaceutics, Pharmacokinetics, and Pharmacodynamics Basic Biopharmaceutics, Pharmacokinetics, and Pharmacodynamics Learning Outcomes Define biopharmaceutics Describe 4 processes of pharmacokinetics Describe factors that affect medication absorption Describe

More information

Pharmacokinetics: The Basics

Pharmacokinetics: The Basics Pharmacokinetics: The Basics 2017 Otsuka Pharmaceutical Development & Commercialization, Inc., Rockville, MD January 2017 MRC2.CORP.D.00200 1 advice or professional diagnosis. Users seeking medical advice

More information

Pharmaceutics I صيدالنيات 1. Unit 2 Route of Drug Administration

Pharmaceutics I صيدالنيات 1. Unit 2 Route of Drug Administration Pharmaceutics I صيدالنيات 1 Unit 2 Route of Drug Administration 1 Routs of Drug administration The possible routes of drug entry into the body may be divided into two classes: Parenteral Rout Enteral Rout

More information

Applied Biopharmaceutics & Pharmacokinetics Sixth Edition

Applied Biopharmaceutics & Pharmacokinetics Sixth Edition Applied Biopharmaceutics & Pharmacokinetics Sixth Edition Hill Leon Shargel, PHD, RPh Applied Biopharmaceutics, LLC Raleigh, North Carolina Affiliate Associate Professor, School of Pharmacy Virginia Commonwealth

More information

Introduction to Pharmacokinetics

Introduction to Pharmacokinetics - 1 - Introduction to Pharmacokinetics Outline accompanies required webcast for Marie Biancuzzo s Lactation Exam Review and Marie Biancuzzo s Comprehensive Lactation Course Notes We will not cover this

More information

Biomath M263 Clinical Pharmacology

Biomath M263 Clinical Pharmacology Training Program in Translational Science Biomath M263 Clinical Pharmacology Spring 2013 www.ctsi.ucla.edu/education/training/webcasts Wednesdays 3 PM room 17-187 CHS 4/3/2013 Pharmacokinetics and Pharmacodynamics

More information

General Pharmacology MCQs

General Pharmacology MCQs General Pharmacology MCQs GP01 [Mar96] A drug is given at a dose of 50 mg/kg to a 70 kg man. The plasma concentration after giving it is 10 mg/ml. The elimination half-life is 8 hours. Clearance would

More information

Drug elimination and Hepatic clearance Chapter 6

Drug elimination and Hepatic clearance Chapter 6 Drug elimination and Hepatic clearance Chapter 6 DRUG ELIMINATION Drugs are removed from the body by various elimination processes. Drug elimination refers to the irreversible removal of drug from the

More information

ICU Volume 11 - Issue 3 - Autumn Series

ICU Volume 11 - Issue 3 - Autumn Series ICU Volume 11 - Issue 3 - Autumn 2011 - Series Impact of Pharmacokinetics of Antibiotics in ICU Clinical Practice Introduction The efficacy of a drug is mainly dependent on its ability to achieve an effective

More information

Biopharmaceutics Lecture-11 & 12. Pharmacokinetics of oral absorption

Biopharmaceutics Lecture-11 & 12. Pharmacokinetics of oral absorption Biopharmaceutics Lecture-11 & 12 Pharmacokinetics of oral absorption The systemic drug absorption from the gastrointestinal (GI) tract or from any other extravascular site is dependent on 1. 2. 3. In the

More information

Mechanisms of Drug Action

Mechanisms of Drug Action 10/31/05 Page 1 20.201 Mechanisms of Drug Action Lecture #18: Pharmacokinetics October 31, 2005 Review Dose-response Protein binding, drug transport(ers) Metabolism NOW: PHARMACOKINETICS Circulatory System

More information

Introduction pharmacology and drug administration

Introduction pharmacology and drug administration 1 Introduction to pharmacology and drug administration INTRODUCTION Pharmacology is the study of drugs or chemicals used to treat and cure disease and their interactions in the body. Within the study of

More information

DEFINITIONS. Pharmacokinetics. Pharmacodynamics. The process by which a drug is absorbed, distributed, metabolized and eliminated by the body

DEFINITIONS. Pharmacokinetics. Pharmacodynamics. The process by which a drug is absorbed, distributed, metabolized and eliminated by the body PHARMACOLOGY BASICS DEFINITIONS Pharmacokinetics The process by which a drug is absorbed, distributed, metabolized and eliminated by the body Pharmacodynamics The interactions of a drug and the receptors

More information

Renal Excretion of Drugs

Renal Excretion of Drugs Renal Excretion of Drugs 3 1 Objectives : 1 Identify main and minor routes of Excretion including renal elimination and biliary excretion 2 Describe its consequences on duration of drugs. For better understanding:

More information

Received: ; Revised; Accepted: A REVIEW ON BIOAVAILABILITY AND BIOEQUIVALENCE STUDY Shashi Kant*, Bharat Parashar

Received: ; Revised; Accepted: A REVIEW ON BIOAVAILABILITY AND BIOEQUIVALENCE STUDY Shashi Kant*, Bharat Parashar International Journal of Institutional Pharmacy and Life Sciences 2(5): September-October 2012 INTERNATIONAL JOURNAL OF INSTITUTIONAL PHARMACY AND LIFE SCIENCES Pharmaceutical Sciences Review Article!!!

More information

NONLINEAR PHARMACOKINETICS: INTRODUCTION

NONLINEAR PHARMACOKINETICS: INTRODUCTION Print Close Window Note: Large images and tables on this page may necessitate printing in landscape mode. Applied Biopharmaceutics & Pharmacokinetics > Chapter 9. Nonlinear Pharmacokinetics > NONLINEAR

More information

PHA First Exam Fall 2013

PHA First Exam Fall 2013 PHA 5127 First Exam Fall 2013 On my honor, I have neither given nor received unauthorized aid in doing this assignment. Name Question Set/Points I. 30 pts II. III. IV 20 pts 20 pts 15 pts V. 25 pts VI.

More information

Volume 1(3) May-June 2013 Page 351

Volume 1(3) May-June 2013 Page 351 ISSN: 2321-5674(Print) BIOAVAILABILITY: CRITERIA FOR APPROVING A DRUG PRODUCT FOR MARKETING Sandhya Singh 1, Faheem Ajmal Ansari 1, Shravan Paswan 2*, Rnjan Kumar Sharma 2, Alok Ranjan Gaur 3 1 Azad Institute

More information

Pharmacokinetic and absolute bioavailability studies in early clinical development using microdose and microtracer approaches.

Pharmacokinetic and absolute bioavailability studies in early clinical development using microdose and microtracer approaches. Pharmacokinetic and absolute bioavailability studies in early clinical development using microdose and microtracer approaches. Lloyd Stevens PhD Senior Research Fellow Pharmaceutical Profiles Nottingham,

More information

Brand and Generic Drugs. Educational Objectives. Absorption

Brand and Generic Drugs. Educational Objectives. Absorption Peter J. Rice, PharmD, PhD Associate Professor of Pharmacology East Tennessee State University Educational Objectives Pharmacokinetic Processes Distribution Metabolism Excretion Similarities Active ingredient(s)

More information

PHA 5128 Spring 2009 First Exam (Version B)

PHA 5128 Spring 2009 First Exam (Version B) Name: UFID: PHA 5128 Spring 2009 First Exam (Version B) On my honor, I have neither given nor received unauthorized aid in doing this assignment. Print: Sign: Version B Q1: Phenytoin (10) Q2: procainamide

More information

Chapter-V Drug use in renal and hepatic disorders. BY Prof. C.Ramasamy, Head, Dept of Pharmacy Practice SRM College of Pharmacy, SRM University

Chapter-V Drug use in renal and hepatic disorders. BY Prof. C.Ramasamy, Head, Dept of Pharmacy Practice SRM College of Pharmacy, SRM University Chapter-V Drug use in renal and hepatic disorders. BY Prof. C.Ramasamy, Head, Dept of Pharmacy Practice SRM College of Pharmacy, SRM University Estimating renal function An accurate estimation of renal

More information

Pharmacokinetic Calculations

Pharmacokinetic Calculations Pharmacokinetic Calculations Introduction. Pharmacokinetics involves the relationship between concentration of drug (and its metabolites), measured most often in plasma, drug dosage, and time. A vast majority

More information